Moreover, the pharmacological delivery of IL-15 reverses fibrosis in models of chronic pancreatitis by promoting the induction of INF-γ, producing NK and NKT cells, and reducing TGF-β levels [18]. This evidence concerns the gene TGFB1 and chronic pancreatitis.